Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Estar Technologies Ltd. is currently overseeing 2 pending office actions within the Biotechnology & Pharmaceuticals technology area. These actions are split between 2 distinct examiners, ensuring that each case is evaluated by a different professional. This distribution is mirrored in the administrative structure, as the cases are also located in 2 distinct art units. This suggests that the company's biotechnological filings are technically diverse enough to be classified into different specialized groups within the patent office.
The busiest examiner for the company is MONTGOMERY, ANN Y, who is assigned 1 busiest examiner pending office action. Because the total number of pending office actions is 2, this examiner is responsible for a significant portion of the company's current workload. This concentration makes the interaction with MONTGOMERY, ANN Y a critical component of the company's immediate prosecution success. Practitioners must be prepared to handle two different sets of art unit standards and two different examiner temperaments. The results of these 2 pending office actions will provide important data on how the company's pharmaceutical innovations are being received across different divisions of the office.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MONTGOMERY, ANN Y | 1 | 69.3% | +27.9% |
| SHAH, NILAY J | 1 | 76.4% | +46.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18684934 | METHOD AND APPARATUS FOR PREPARING PLASMA ENRICHED IN IL-1RA | MONTGOMERY, ANN Y | — |
| 18395751 | SYRINGE DEVICE PLUNGER WITH AXIALLY EXTENDABLE DETENTS AND METHODS OF USING AND PROCESSES OF MANUFACTURING THE SAME | SHAH, NILAY J | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18684934 | METHOD AND APPARATUS FOR PREPARING PLASMA ENRICHED IN IL-1RA | MONTGOMERY, ANN Y | — |
| 18395751 | SYRINGE DEVICE PLUNGER WITH AXIALLY EXTENDABLE DETENTS AND METHODS OF USING AND PROCESSES OF MANUFACTURING THE SAME | SHAH, NILAY J | — |
| Art Unit | Apps |
|---|---|
| 1678 | 1 |
| 3783 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18684934 | METHOD AND APPARATUS FOR PREPARING PLASMA ENRICHED IN IL-1RA | MONTGOMERY, ANN Y | 1678 | §102§103 | Non-Final OA | — | Pending | Feb 20, 2024 |
| 18395751 | SYRINGE DEVICE PLUNGER WITH AXIALLY EXTENDABLE DETENTS AND METHODS OF USING AND PROCESSES OF MANUFACTURING THE SAME | SHAH, NILAY J | 3783 | §102§103§112 | Non-Final OA | — | Pending | Dec 26, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialEstar Technologies Ltd. has 2 pending office actions as of November 2026, spread across 2 art units and 2 examiners.
Ann Y Montgomery has the most, with 1 of Estar Technologies Ltd.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.